|
|
||||||||
Journal of Lipid Research, Vol 37, 2557-2568, Copyright © 1996 by Lipid Research, Inc.
P Uboldi, M Spoladore, S Fantappie, S Marcovina and AL Catapano
Eight murine monoclonal antibodies (Mab) to apolipoprotein A-I were
characterized for their epitopes and for their ability to interfere with
lecithin:cholesterol acyltransferase (LCAT) activation mediated by apo
apoA-I using a synthetic substrate. Using overlapping synthetic peptides we
have identified six continuous epitopes that span amino acids 1-10 (Mab
A-I-19), 96-101 (Mab A-I-15), 133-141 (Mab A-I-5), 140- 145 (Mab A-I-9),
144-148 (Mab A-I-8), and 167-174 (Mab A-I-57). Furthermore, antibodies
A-I-11 and A-I-16 recognized discontinuous epitopes, namely amino acids
124-128 and 144-148. When antibodies were tested for their ability to
inhibit LCAT activation, an inhibitory effect was observed with those whose
epitopes covered the area of apoA- I encompassing amino acids 96-174. From
these data we conclude that several areas of apoA-I spanning the middle
region of the apolipoprotein act in concert to stimulate LCAT activity,
possibly by cooperative interaction with the enzyme.
ARTICLES
Localization of apolipoprotein A-I epitopes involved in the activation of lecithin:cholesterol acyltransferase
Institute of Pharmacological Sciences, University of Milano, Italy.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. A. Liz, C. M. Gomes, M. J. Saraiva, and M. M. Sousa ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity J. Lipid Res., November 1, 2007; 48(11): 2385 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lee, P. Uboldi, D. Giudice, A. L. Catapano, and P. T. Kovanen Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase: implications for HDL function J. Lipid Res., June 1, 2000; 41(6): 975 - 984. [Abstract] [Full Text] |
||||
![]() |
D. C. McManus, B. R. Scott, P. G. Frank, V. Franklin, J. R. Schultz, and Y. L. Marcel Distinct Central Amphipathic alpha -Helices in Apolipoprotein A-I Contribute to the in Vivo Maturation of High Density Lipoprotein by Either Activating Lecithin-Cholesterol Acyltransferase or Binding Lipids J. Biol. Chem., February 18, 2000; 275(7): 5043 - 5051. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Daum, T. P. Leren, C. Langer, A. Chirazi, P. Cullen, P. H. Pritchard, G. Assmann, and A. von Eckardstein Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers J. Lipid Res., March 1, 1999; 40(3): 486 - 494. [Abstract] [Full Text] |
||||
![]() |
M. G. Sorci-Thomas, L. Curtiss, J. S. Parks, M. J. Thomas, M. W. Kearns, and M. Landrum The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143-164 Regulates Lecithin:Cholesterol Acyltransferase Activation J. Biol. Chem., May 8, 1998; 273(19): 11776 - 11782. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sviridov, A. Hoang, W. H. Sawyer, and N. H. Fidge Identification of a Sequence of Apolipoprotein A-I Associated with the Activation of Lecithin:Cholesterol Acyltransferase J. Biol. Chem., June 23, 2000; 275(26): 19707 - 19712. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. McManus, B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel Proteolytic Degradation and Impaired Secretion of an Apolipoprotein A-I Mutant Associated with Dominantly Inherited Hypoalphalipoproteinemia J. Biol. Chem., June 8, 2001; 276(24): 21292 - 21302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |